Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |